Imvax Gets Positive Overall Survival Data From Phase IIb GBM Asset

 
• By Alaric DeArment
  
glioblastoma
Imvax announced positive topline Phase IIb data for IGV-001 in GBM • Source: Shutterstock

More from Clinical Trials

More from R&D